Confluent (CFLT) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Zacks
Confluent (CFLT) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended December 2025, Confluent (CFLT) reported revenue of $314.82 million, up 20.5% over the same period last year. EPS came in at $0.12, compared to $0.09 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $307.29 million, representing a surprise of +2.45%. The company delivered an EPS surprise of +22.08%, with the consensus EPS estimate being $0.10.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Confluent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Services: $13.17 million compared to the $10.96 million average estimate based on eight analysts. The reported number represents a change of +24.5% year over year. Revenue- Subscription: $301.65 million compared to the $295.97 million average estimate based on eight analysts. The reported number represents a change of +20.4% year over year. Revenue- Confluent Cloud: $169 million compared to the $165.22 million average estimate based on six analysts. The reported number represents a change of +22.5% year over year.

View all Key Company Metrics for Confluent here>>>

Shares of Confluent have returned +0.6% over the past month versus the Zacks S&P 500 composite's -0.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Confluent, Inc. (CFLT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other news